Real‐world adjuvant chemotherapy treatment patterns and outcomes over time for resected stage II and III colorectal cancer

Abstract

Background:The administration of adjuvant chemotherapy (AC) to colorectal cancer (CRC) patients in Australia and impact of recent trial data has not been well reported.We aim to evaluate temporal trends in AC treatment and outcomes in real-world Australian patients.Methods: CRC patients were analyzed from 13 hospitals, stratified by stage (II or III)